stockrowDr. Reddy's Laboratories Ltd (RDY) vs Viatris Inc. (VTRS)
- Dr. Reddy's Laboratories Ltd RDY 14.53 −1.62%
- Viatris Inc. VTRS 18.89 −1.72%
Dr. Reddy's Laboratories Ltd and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Viatris Inc. is the larger, with a market value of $21.8B against $12.1B — 1.8× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; Dr. Reddy's Laboratories Ltd trades at 44.4×. Viatris Inc. grew revenue faster over the last twelve months: 4.27% against −15.5%. Dr. Reddy's Laboratories Ltd has the higher net margin (8.06% vs −4.13%) and the higher return on invested capital (4.77% vs −0.02%). Only Viatris Inc. pays a dividend (2.54%). Across the 22 metrics below, Dr. Reddy's Laboratories Ltd leads on 12 and Viatris Inc. on 10.
Valuation
Profitability
| Metric | RDY | VTRS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 49.16% | 35.31% | 53.51% |
| Operating margin | 9.20% | (0.03%) | 0.00% |
| Net margin | 8.06% | (4.13%) | (2.45%) |
| Free cash flow margin | 2.88% | 16.27% | 0.00% |
| Return on equity | 6.60% | (4.21%) | (0.80%) |
| Return on assets | 4.44% | (1.67%) | (1.67%) |
| Return on invested capital | 4.77% | (0.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack